Skip to main content

Table 1 Clinical and laboratory features at conception and treatment in 46 SLE patients during 47 pregnancies.

From: Effect of pregnancy on serum cytokines in SLE patients

 

No. of patients (%)

Skin manifestations

16 (35)

Arthralgias and/or arthritis

26 (56)

Serositis

4 (8.7)

Glomerulonephritis

16 (34)

CNS involvement

2 (4.3)

Hematological involvement

26 (56)

Anti-dsDNA Ab

33 (71.7)

Anti-Sm Ab

6 (13)

Anti-U1RNP Ab

10 (21.7)

Anti-Ro/SSA Ab

17 (37)

Anticardiolipin Ab

20 (43.5)

LAC

7 (15.2)

Double LAC + aCL positivity

6 (13)

Prednisone

36 (78)

Antimalarials

18 (39)

Azathioprine

11 (24)

No therapy

5 (11)

  1. Hematological involvement, excluding hemolytic anemia. Ab, anti-extractable nuclear antigens antibodies (anti-ENA); aCL, anticardiolipin antibodies Anti-dsDNA Ab, anti-double-stranded-DNA antibodies; anti-Sm, anti-U1RNP, anti-Ro/SSA; CNS, central nervous system; LAC, lupus anticoagulant